Were the Nexxen (NEXN) CFO share sales made under a Rule 10b5-1 plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Niri Sagi on 08/19/2025 . Rule 10b5-1 plans pre-arrange trading instructions so that later trades follow the preset plan rather than day-to-day discretionary decisions.

Nexxen International (NEXN) CFO sells 42,692 shares in planned trades

Q: What insider transaction did Nexxen (NEXN) disclose in this Form 4/A?

Nexxen International Ltd. reported that CFO Niri Sagi sold 42,692 shares of common stock on July 1, 2026 under a Rule 10b5-1 trading plan. The sales occurred in three separate transactions and were previously omitted from the original Form 4 filed on that date.

Q: How many Nexxen (NEXN) shares did CFO Niri Sagi sell and at what prices?

CFO Niri Sagi sold three blocks of Nexxen common stock: 12,717 shares at $9.1342 , 23,391 shares at $9.4429 and 6,584 shares at $9.5232 . In total, the amended Form 4 reports sales of 42,692 shares of common stock on July 1, 2026.

Q: Why was this Nexxen (NEXN) Form 4/A filed as an amendment?

The Form 4/A explains that these sales were inadvertently omitted from the original Form 4 filed on July 01, 2026. This amendment corrects the reporting record by adding the three previously unreported transactions in Nexxen common stock executed by CFO Niri Sagi.

Q: What is the net effect of the reported Nexxen (NEXN) trades?

Across the three transactions, the Form 4/A shows net selling of 42,692 shares of Nexxen common stock by CFO Niri Sagi. All reported entries are sales of non-derivative common stock; there are no option exercises, gifts, or derivative security transactions disclosed in this filing.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

4/A

Rhea-AI Filing Summary

Nexxen International Ltd. reports that Chief Financial Officer Niri Sagi sold a total of 42,692 shares of common stock on July 01, 2026 in three transactions of 12717, 23391 and 6584 shares at per-share prices of $9.1342, $9.4429 and $9.5232, respectively. The sales were executed under a Rule 10b5-1 trading plan adopted on August 19, 2025 and are being reported in this amended filing because they were inadvertently omitted from the original Form 4.

Insider Trade Summary 10b5-1

Net Seller: 42,692 shares

Net Sell 3 txns

Insider Niri Sagi

Role Chief Financial Officer

Sold 42,692 shs ($400K)

Type	Security	Shares	Price	Value
Sale	Common Stock ^F1	12,717	$9.1342	$116K
Sale	Common Stock ^F1	23,391	$9.4429	$221K
Sale	Common Stock ^F1	6,584	$9.5232	$63K

Holdings After Transaction: Common Stock — 339,091 shares (Direct)

Footnotes (1)

F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. Such sales were inadvertently omitted from the original Form 4 filed by the reporting person on July 01, 2026.

Key Figures

Total shares sold: 42692 shares First sale tranche: 12717.0000 shares at $9.1342 Second sale tranche: 23391.0000 shares at $9.4429 +3 more

6 metrics

Total shares sold 42692 shares Aggregate Nexxen common shares sold by CFO Niri Sagi on 2026-07-01

First sale tranche 12717.0000 shares at $9.1342 Non-derivative common stock sale on 2026-07-01

Second sale tranche 23391.0000 shares at $9.4429 Non-derivative common stock sale on 2026-07-01

Third sale tranche 6584.0000 shares at $9.5232 Non-derivative common stock sale on 2026-07-01

Rule 10b5-1 plan adoption date 08/19/2025 Date CFO Niri Sagi adopted the trading plan governing these sales

Net buy/sell shares -42692 shares Net share change from reported transactions (all sales)

Key Terms

Rule 10b5-1 trading plan, Form 4, non-derivative

3 terms

Rule 10b5-1 trading plan regulatory

"The sales reported ... were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Form 4 regulatory

"Such sales were inadvertently omitted from the original Form 4 filed"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

non-derivative financial

"transaction_type": "non-derivative" for each common stock sale entry"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/22/2026 - 09:34 AM Accepted by SEC EDGAR 07/22/2026 - 09:34 AM

FAQ

What insider transaction did Nexxen (NEXN) disclose in this Form 4/A?

Nexxen International Ltd. reported that CFO Niri Sagi sold 42,692 shares of common stock on July 1, 2026 under a Rule 10b5-1 trading plan. The sales occurred in three separate transactions and were previously omitted from the original Form 4 filed on that date.

How many Nexxen (NEXN) shares did CFO Niri Sagi sell and at what prices?

CFO Niri Sagi sold three blocks of Nexxen common stock: 12,717 shares at $9.1342, 23,391 shares at $9.4429 and 6,584 shares at $9.5232. In total, the amended Form 4 reports sales of 42,692 shares of common stock on July 1, 2026.

Why was this Nexxen (NEXN) Form 4/A filed as an amendment?

The Form 4/A explains that these sales were inadvertently omitted from the original Form 4 filed on July 01, 2026. This amendment corrects the reporting record by adding the three previously unreported transactions in Nexxen common stock executed by CFO Niri Sagi.

What is the net effect of the reported Nexxen (NEXN) trades?

Across the three transactions, the Form 4/A shows net selling of 42,692 shares of Nexxen common stock by CFO Niri Sagi. All reported entries are sales of non-derivative common stock; there are no option exercises, gifts, or derivative security transactions disclosed in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Niri Sagi

(Last)

(First)

(Middle)

82 YIGAL ALON STREET

(Street)

TEL AVIV

6789124

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nexxen International Ltd. [ NEXN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
07/01/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/01/2026		S⁽¹⁾		12,717	D	$9.1342	369,066	D
Common Stock	07/01/2026		S⁽¹⁾		23,391	D	$9.4429	345,675	D
Common Stock	07/01/2026		S⁽¹⁾		6,584	D	$9.5232	339,091	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025. Such sales were inadvertently omitted from the original Form 4 filed by the reporting person on July 01, 2026.

	/s/ Shai Shulman	07/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR